Literature DB >> 9737781

Direct evidence of autosomal recessive inheritance of Arg24 to termination codon in purine nucleoside phosphorylase gene in a family with a severe combined immunodeficiency patient.

Y Sasaki1, M Iseki, S Yamaguchi, Y Kurosawa, T Yamamoto, Y Moriwaki, T Kenri, T Sasaki, R Yamashita.   

Abstract

Purine nucleoside phosphorylase (PNP) deficiency is a rare immunodeficiency disease involving a T-lymphocyte-dysfunction that is fatal unless bone marrow transplantation is successful. In this study we undertook genetic analysis of a patient with PNP deficiency. Sequencing of the PNP gene, which is located on chromosome 14ql3, of the patient led to the identification of three point mutations in exon 2 at amino acid positions 20 (His, silent mutation), 24 (Arg-->termination codon) and 51 (Ser-->Gly). Intrafamilial sequence analysis of exon 2 revealed that both parents were heterozygous for the Arg24 and termination codon 24 alleles. Two of their three children had inherited different homozygous alleles, termination codon 24 for the patient, and Arg24 for his healthy sibling. Transcriptional termination was suggested as the mechanism giving rise to the disorder in this case. A lack of PNP protein was also confirmed by immunoblot analysis of the patient's hemolysate. This could be the first report providing evidence of autosomal recessive inheritance in PNP deficiency by sequence-based analysis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737781     DOI: 10.1007/s004390050787

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  10 in total

1.  Purine nucleoside phosphorylase deficiency with a novel PNP gene mutation: a first case report from India.

Authors:  Manisha Rajan Madkaikar; Shilpa Kulkarni; Prashant Utage; Lynette Fairbanks; Kanjaksha Ghosh; Anthony Marinaki; Mukesh Desai
Journal:  BMJ Case Rep       Date:  2011-12-08

2.  Defining biological subsets in systemic lupus erythematosus: progress toward personalized therapy.

Authors:  Nailú Angélica Sinicato; Mariana Postal; Simone Appenzeller; Timothy B Niewold
Journal:  Pharmaceut Med       Date:  2017-01-25

3.  High IL-18 (interferon-gamma inducing factor) concentration in a purine nucleoside phosphorylase deficient patient.

Authors:  T Yamamoto; Y Moriwaki; K Matsui; S Takahashi; H Tsutsui; T Yoshimoto; H Okamura; K Nakanishi; Y Kurosawa; S Yamaguchi; Y Sasaki; K Higashino
Journal:  Arch Dis Child       Date:  1999-08       Impact factor: 3.791

Review 4.  Purine nucleoside phosphorylase as a target to treat age-associated lower urinary tract dysfunction.

Authors:  Lori A Birder; Edwin K Jackson
Journal:  Nat Rev Urol       Date:  2022-09-07       Impact factor: 16.430

5.  Drug off-target effects predicted using structural analysis in the context of a metabolic network model.

Authors:  Roger L Chang; Li Xie; Lei Xie; Philip E Bourne; Bernhard Ø Palsson
Journal:  PLoS Comput Biol       Date:  2010-09-23       Impact factor: 4.475

6.  Lupus-Associated Functional Polymorphism in PNP Causes Cell Cycle Abnormalities and Interferon Pathway Activation in Human Immune Cells.

Authors:  Yogita Ghodke-Puranik; Jessica M Dorschner; Danielle M Vsetecka; Shreyasee Amin; Ashima Makol; Floranne Ernste; Thomas Osborn; Kevin Moder; Vaidehi Chowdhary; Elias Eliopoulos; Maria I Zervou; George N Goulielmos; Mark A Jensen; Timothy B Niewold
Journal:  Arthritis Rheumatol       Date:  2017-11-09       Impact factor: 10.995

7.  Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus.

Authors:  S N Kariuki; Y Ghodke-Puranik; J M Dorschner; B S Chrabot; J A Kelly; B P Tsao; R P Kimberly; M E Alarcón-Riquelme; C O Jacob; L A Criswell; K L Sivils; C D Langefeld; J B Harley; A D Skol; T B Niewold
Journal:  Genes Immun       Date:  2014-10-23       Impact factor: 2.676

8.  Prevalence and complications of hypouricemia in a general population: A large-scale cross-sectional study in Japan.

Authors:  Masanari Kuwabara; Koichiro Niwa; Akira Ohtahara; Toshihiro Hamada; Satoshi Miyazaki; Einosuke Mizuta; Kazuhide Ogino; Ichiro Hisatome
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

9.  Purine nucleoside phosphorylase inhibition ameliorates age-associated lower urinary tract dysfunctions.

Authors:  Lori A Birder; Amanda Wolf-Johnston; Alan J Wein; Fangzhou Cheng; Mara Grove-Sullivan; Anthony J Kanai; Alan M Watson; Donna Stoltz; Simon C Watkins; Anne M Robertson; Diane Newman; Roger R Dmochowski; Edwin K Jackson
Journal:  JCI Insight       Date:  2020-10-15

Review 10.  Hypouricemia and Urate Transporters.

Authors:  Naoyuki Otani; Motoshi Ouchi; Kazuharu Misawa; Ichiro Hisatome; Naohiko Anzai
Journal:  Biomedicines       Date:  2022-03-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.